Last updated on February 2018

Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Multiple Myeloma in Older Patients
  • Age: Between 70 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients aged 70 years and older
  • Patients referred for a assessment of a newly diagnosed multiple myeloma
  • Patients for who the initial therapy proposed is either melphalan-prednisone-thalidomide or melphalan-prednisone-bortezomib or included in a phase 3 trial.
  • Patients who provide informed written consent

Exclusion Criteria:

  • Patients who refuse the study
  • Patients who won't have therapy
  • Patients can't respond to geriatric assessment because of severe cognitive disorder
  • Patients with a legal guardian

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.